We are live on ! Find out more
LENZ

LENZ Therapeutics
LENZ

51 hedge funds and large institutions have $981M invested in LENZ Therapeutics in 2021 Q2 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8.21% more ownership

Funds ownership: 0% → 8.21% (+8.2%)

Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
+$185M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$93.6M
3
RCM
RA Capital Management
Massachusetts
+$67.1M
4
RSCM
Rock Springs Capital Management
Maryland
+$53.5M
5
VA
VR Adviser
New York
+$40.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Suvretta Capital Management
New York
$3.84M +$3.11M +17,857 New
BlackRock
27
BlackRock
New York
$3.18M +$2.58M +14,797 New
Blackstone Inc
28
Blackstone Inc
New York
$2.31M +$1.87M +10,714 New
LP
29
LMR Partners
United Kingdom
$2.15M +$1.74M +10,000 New
MIM
30
Monashee Investment Management
Massachusetts
$1.84M +$1.49M +8,571 New
PCM
31
Pinz Capital Management
New York
$1.61M +$1.31M +7,506 New
ACM
32
Asymmetry Capital Management
California
$1.57M +$1.27M +7,291 New
CCM
33
CAAS Capital Management
New York
$1.23M +$995K +5,714 New
GCM
34
Ghisallo Capital Management
Massachusetts
$1.23M +$995K +5,714 New
Squarepoint
35
Squarepoint
New York
$1.23M +$995K +5,714 New
MWNA
36
Marshall Wace North America
New York
$1.13M +$912K +5,235 New
Alyeska Investment Group
37
Alyeska Investment Group
Illinois
$922K +$747K +4,286 New
Vanguard Group
38
Vanguard Group
Pennsylvania
$921K +$747K +4,286 New
DKCM
39
Davidson Kempner Capital Management
New York
$768K +$622K +3,571 New
SFM
40
Sphera Funds Management
Israel
$767K +$621K +3,565 New
Voloridge Investment Management
41
Voloridge Investment Management
Florida
$615K +$498K +2,857 New
Balyasny Asset Management
42
Balyasny Asset Management
Illinois
$591K +$478K +2,747 New
Jane Street
43
Jane Street
New York
$468K +$379K +2,175 New
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$452K +$366K +2,100 New
MS
45
Maven Securities
Jersey
$389K +$311K +1,786 New
Tudor Investment Corp
46
Tudor Investment Corp
Connecticut
$369K +$299K +1,714 New
Point72 Asset Management
47
Point72 Asset Management
Connecticut
$307K +$249K +1,429 New
VF
48
Virtu Financial
New York
$237K +$192K +1,101 New
PHK
49
Point72 Hong Kong
Hong Kong
$79K +$64.1K +368 New
Bank of America
50
Bank of America
North Carolina
$6K +$5.05K +29 New
1
2
3

LENZ Hedge Fund Activity: Q2 2021 in Review

51 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in LENZ Therapeutics (LENZ) for Q2 2021, worth a combined $981M.

Buyers outnumbered sellers: 51 funds opened new LENZ positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Samsara BioCapital, opening a new position worth an estimated $185M.

  • 51 institutional investors held LENZ Therapeutics (LENZ) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $981M of LENZ Therapeutics stock for Q2 2021.
  • 51 funds opened new LENZ Therapeutics positions in Q2 2021 and 0 closed out, a net change of +51 holders.
  • The largest LENZ Therapeutics buyer in Q2 2021 was Samsara BioCapital, an estimated $185M added.

Based on aggregated 13F filings for Q2 2021.